Through its new Bid Efficiency feature, DeepIntent has effectively reduced its bid data processing by one-third NEW YORK, February 22, 2023 – DeepIntent, the …
More than 600 pharmaceutical brands now use DeepIntent to simplify campaign planning, activation, measurement, and optimization NEW YORK, January 11, 2023 – DeepIntent, the …
NEW YORK, Dec. 15, 2022 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, …
Follows Recent Launch of DeepIntent’s Innovative Patient Planner to Simplify Audience Creation and Campaign Activation NEW YORK, October 17, 2022 – DeepIntent, the leading …
Company to be featured Oct. 3 in the New York’s Most Respected Employers Issue NEW YORK, September 30, 2022 – DeepIntent, the leading healthcare …
NEW YORK, September 23, 2022 – PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, recently named …
Latest Innovation Solves Pharma Brands’ and Agencies’ Long-standing Need for Transparent, Data-driven DTC Audience Creation and Campaign Planning NEW YORK, September 7, 2022 – …
Seasoned Executive Brings Expertise with High-Growth Companies as Pharma Programmatic Advertising Spending Dramatically Increases NEW YORK, August 8, 2022 – DeepIntent, the leading healthcare …
Over two dozen pharma brands and agencies have embraced the industry’s first and only healthcare-specific data marketplace with hundreds of ready-to-activate custom segments NEW …